These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12102473)

  • 1. Combination therapy with cyclosporine and methotrexate in patients with early rheumatoid arthritis soon inhibits TNFalpha production without decreasing TNFalpha mRNA levels. An in vivo and in vitro study.
    Giacomelli R; Cipriani P; Matucci Cerinic M; Fulminis A; Barattelli G; Pingiotti E; Di Franco M; Trotta A; Perricone R; Zazzeroni F; Alesse E; Tonietti G
    Clin Exp Rheumatol; 2002; 20(3):365-72. PubMed ID: 12102473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment.
    Seitz M; Zwicker M; Wider B
    J Rheumatol; 2001 Mar; 28(3):496-501. PubMed ID: 11296948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy.
    Baraldo M; Ferraccioli G; Pea F; Gremese E; Furlanut M
    Pharmacol Res; 1999 Dec; 40(6):483-6. PubMed ID: 10660945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Step-down approach using either cyclosporin A or methotrexate as maintenance therapy in early rheumatoid arthritis.
    Marchesoni A; Battafarano N; Arreghini M; Pellerito R; Cagnoli M; Prudente P; Cerase A; Priolo F; Tosi S
    Arthritis Rheum; 2002 Feb; 47(1):59-66. PubMed ID: 11932879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis.
    Hobl EL; Mader RM; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Kalipciyan M; Jilma B
    Clin Exp Rheumatol; 2011; 29(6):963-9. PubMed ID: 22133036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate chronotherapy is effective against rheumatoid arthritis.
    To H; Yoshimatsu H; Tomonari M; Ida H; Tsurumoto T; Tsuji Y; Sonemoto E; Shimasaki N; Koyanagi S; Sasaki H; Ieiri I; Higuchi S; Kawakami A; Ueki Y; Eguchi K
    Chronobiol Int; 2011 Apr; 28(3):267-74. PubMed ID: 21452922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate.
    Varani K; Massara A; Vincenzi F; Tosi A; Padovan M; Trotta F; Borea PA
    Arthritis Rheum; 2009 Oct; 60(10):2880-91. PubMed ID: 19790066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine A in the treatment of early rheumatoid arthritis. A prospective, randomized 24-month study.
    Drosos AA; Voulgari PV; Papadopoulos IA; Politi EN; Georgiou PE; Zikou AK
    Clin Exp Rheumatol; 1998; 16(6):695-701. PubMed ID: 9844762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of refractory rheumatoid arthritis. Cyclosporin and methotrexate combination].
    Danieli MG; Fratini M; Rossetti L; Giovagnoni A; Amici F; Danieli G
    Recenti Prog Med; 1998 Jan; 89(1):7-13. PubMed ID: 9549386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study.
    Hetland ML; Stengaard-Pedersen K; Junker P; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen A; Tarp U; Pødenphant J; Hansen G; Lindegaard H; de Carvalho A; Østergaard M; Hørslev-Petersen K;
    Arthritis Rheum; 2006 May; 54(5):1401-9. PubMed ID: 16645967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine differentially regulates interleukin-10, interleukin-15, and tumor necrosis factor a production by rheumatoid synoviocytes.
    Cho ML; Kim WU; Min SY; Min DJ; Min JK; Lee SH; Park SH; Cho CS; Kim HY
    Arthritis Rheum; 2002 Jan; 46(1):42-51. PubMed ID: 11817607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction.
    Constantin A; Loubet-Lescoulié P; Lambert N; Yassine-Diab B; Abbal M; Mazières B; de Préval C; Cantagrel A
    Arthritis Rheum; 1998 Jan; 41(1):48-57. PubMed ID: 9433869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of interleukin-1 beta, tumor necrosis factor alpha, interleukins-6, -10 and -4, and metalloproteases by freshly isolated mononuclear cells from early never-treated and non-acute treated rheumatoid arthritis patients.
    Vázquez-Del Mercado M; Delgado-Rizo V; Muñoz-Valle JF; Orozco-Alcalá J; Volk HD; Armendáriz-Borunda J
    Clin Exp Rheumatol; 1999; 17(5):575-83. PubMed ID: 10544841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.
    Bakker MF; Jacobs JW; Welsing PM; Verstappen SM; Tekstra J; Ton E; Geurts MA; van der Werf JH; van Albada-Kuipers GA; Jahangier-de Veen ZN; van der Veen MJ; Verhoef CM; Lafeber FP; Bijlsma JW;
    Ann Intern Med; 2012 Mar; 156(5):329-39. PubMed ID: 22393128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIF and TNFα serum levels in rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs: a cross-sectional study.
    Brennan-Bourdon LM; De la Cruz-Mosso U; Reyes-Castillo Z; Martínez-Bonilla GE; Ramírez-Dueñas MG; Islas-Carbajal MC; Rincón-Sánchez AR; Salazar-Páramo M; Muñoz-Valle JF
    Immunopharmacol Immunotoxicol; 2015 Apr; 37(2):207-13. PubMed ID: 25721154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.
    Breedveld FC; Weisman MH; Kavanaugh AF; Cohen SB; Pavelka K; van Vollenhoven R; Sharp J; Perez JL; Spencer-Green GT
    Arthritis Rheum; 2006 Jan; 54(1):26-37. PubMed ID: 16385520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modern treatment strategies in rheumatoid arthritis.
    Hetland ML
    Dan Med Bull; 2011 Nov; 58(11):B4320. PubMed ID: 22047935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis.
    Macías I; García-Pérez S; Ruiz-Tudela M; Medina F; Chozas N; Girón-González JA
    J Rheumatol; 2005 Nov; 32(11):2102-8. PubMed ID: 16265686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of methotrexate on the expression of the translational isoforms of glucocorticoid receptors α and β: correlation with methotrexate efficacy in rheumatoid arthritis patients.
    Gatica H; Aliste M; Guerrero J; Goecke IA
    Rheumatology (Oxford); 2011 Sep; 50(9):1665-71. PubMed ID: 21642336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.